Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Avalon GloboCare
AddedFeb 19, 2024
UpdatedJun 18, 2026
Avalon GloboCare

Avalon GloboCare

Public

Avalon GloboCare: A global biotech firm specializing in stem cell banking, oral cancer detection, and skin regeneration.

HQ
Freehold, NJ, US
Founded
2014
Overview
Compare
Fundraising
Employees
Website

Avalon GloboCare, founded with a mission to revolutionize biotechnology and healthcare services, focuses on developing diagnostic and therapeutic products. The company specializes in stem cell banking, oral cancer detection, and skin regeneration. Additionally, Avalon GloboCare has expanded its product line to include the KetoAir Breathalyzer, which monitors ketosis levels. Their market focus spans globally, serving clients worldwide with innovative healthcare solutions.

Notable figures affiliated with Avalon GloboCare include key investors and industry experts who have propelled the company's growth. The firm has achieved significant milestones, such as launching the KetoAir Breathalyzer in the U.S. and securing an exclusivity agreement for its distribution across multiple regions. Avalon GloboCare's impact is evident in its contributions to advancing medical diagnostics and therapeutic technologies, positioning itself as a leader in the biotech industry.

Avalon GloboCare - Similar Companies

Avra logo

Avra

StemSave logo

StemSave

stemsave.com

Avalo Therapeutics logo

Avalo Therapeutics

avalotx.com

Stemcyte logo

Stemcyte

stemcyte.com

American CryoStem logo

American CryoStem

AVM Biotechnology logo

AVM Biotechnology

avmbiotech.com

Avalon Health Services logo

Avalon Health Services

avalonhcs.com

Next Healthcare logo

Next Healthcare

AVITA Medical logo

AVITA Medical

avitamedical.com

Gallant logo

Gallant

Longeveron logo

Longeveron

longeveron.com

Stemgenics logo

Stemgenics

stemgenics.com

Personalized Stem Cells logo

Personalized Stem Cells

Celularity logo

Celularity

celularity.com

StemBioSys logo

StemBioSys

stembiosys.com

Avalon GloboCare - Quick Facts

Who are Avalon GloboCare's competitors?

Companies similar to Avalon GloboCare include Avra, StemSave, Avalo Therapeutics and Stemcyte.

When was Avalon GloboCare founded?

Avalon GloboCare was founded in 2014.

Where is Avalon GloboCare's headquarters located?

Avalon GloboCare's headquarters is located in Freehold, NJ, US.

When was Avalon GloboCare's last funding round?

Avalon GloboCare's most recent funding round was for $20M (USD) in September 2019.

How much has Avalon GloboCare raised to-date?

As of Sep 3, 2019, Avalon GloboCare has raised a total of $25.1M (USD).

How many employees does Avalon GloboCare have?

Avalon GloboCare has 5 employees as of Feb 5, 2024.

Avalon GloboCare - Classification

Industry
  • Professional Service Companies
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Stem Cell Banking
Tags
  • Biotech
Unique IDs
  • ein: 471685128
  • secCik: 0001630212
  • ticker: ALBT
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 45 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 334600Manufacturing and Reproducing Magnetic and Optical Media
  • 513200Software Publishers
  • 541611Administrative Management and General Management Consulting Services
  • 541612Human Resources Consulting Services
  • 561300Employment Services
  • 561310Employment Placement Agencies and Executive Search Services
  • 561312Executive Search Services
  • 330000Manufacturing
  • 510000Information
  • 560000Administrative and Support and Waste Management and Remediation Services
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 334000Computer and Electronic Product Manufacturing
  • 513000Publishing Industries
  • 561000Administrative and Support Services
  • 623000Nursing and Residential Care Facilities
  • 541600Management, Scientific, and Technical Consulting Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 334610Manufacturing and Reproducing Magnetic and Optical Media
  • 513210Software Publishers
  • 541610Management Consulting Services
  • 325412Pharmaceutical Preparation Manufacturing
  • 541613Marketing Consulting Services
  • 541614Process, Physical Distribution, and Logistics Consulting Services
SIC
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 7300Business Services
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8740Management And Public Relations Services
  • 2834Pharmaceutical Preparations
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
  • 8742Management Consulting Services
ISIC
  • 1820Reproduction of recorded media
  • 5820Software publishing
  • 7020Management consultancy activities
  • 7810Activities of employment placement agencies